Welcome to LookChem.com Sign In|Join Free
  • or
1-(2-chloro-4-nitrobenzyl)-4-methylpiperazine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

943320-66-9

Post Buying Request

943320-66-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

943320-66-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 943320-66-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,3,2 and 0 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 943320-66:
(8*9)+(7*4)+(6*3)+(5*3)+(4*2)+(3*0)+(2*6)+(1*6)=159
159 % 10 = 9
So 943320-66-9 is a valid CAS Registry Number.

943320-66-9Relevant academic research and scientific papers

Design, synthesis and biological evaluation of coumarin derivatives as novel acetylcholinesterase inhibitors that attenuate H2O2-induced apoptosis in SH-SY5Y cells

Yao, Dahong,Wang, Jing,Wang, Guan,Jiang, Yingnan,Shang, Lei,Zhao, Yuqian,Huang, Jian,Yang, Shilin,Wang, Jinhui,Yu, Yamei

, p. 112 - 123 (2016/08/01)

A novel series of coumarin derivatives were designed, synthesized and investigated for inhibition of cholinesterase, including acetyl cholinesterase (AChE) and butyrylcholinesterase (BuChE). This biological study showed that these compounds containing piperazine ring had significant inhibition activities on AChE rather than BuChE. Further study suggested that 9x, as one of this kind of structure derivative, showed the strongest inhibition activity on AChE with an IC50 value of 34?nM. Moreover, molecular docking, flow cytometry (FCM), and western blot assay suggested that 9x could induce cytoprotective autophagy to attenuate H2O2-induced cell death in human neuroblastoma SH-SY5Y cells. These findings highlight a new approach for the development of a novel potential neuroprotective compound targeting AChE with autophagy-inducing activity in future Alzheimer's disease (AD) therapy.

METHODS AND COMPOSITIONS FOR RAF KINASE MEDIATED DISEASES

-

, (2013/11/18)

The invention discloses methods and compositions for treating or preventing RAF kinase mediated diseases or conditions by administering a compound of Formula 1: or a pharmaceutically acceptable salt, solvate or hydrate thereof, wherein the variables are defined as herein.

BICYCLIC HETEROARYL COMPOUNDS

-

Page/Page column 69, (2008/06/13)

This invention relates to compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 943320-66-9